心力衰竭的新型药物治疗及管理  

NEW DRUGS THERAPY AND MANAGEMENT OF HEART FAILURE

作　　者：李雪[1] 贾海玉[2] LI Xue;JIA Haiyu(Inner Mongolia Medical University,Hohhot 010059,China;Department of Geriatrics Center,The Affiliated Hospital of Inner Mongolia Medical University,Hohhot 010050,China)

机构地区：[1]内蒙古医科大学,内蒙古呼和浩特010059 [2]内蒙古医科大学附属医院老年医学中心,内蒙古呼和浩特010050

出　　处：《内蒙古医科大学学报》2022年第6期645-648,654,共5页Journal of Inner Mongolia Medical University

基　　金：内蒙古自治区自然科学基金项目(2021MS08148)。

摘　　要：心力衰竭(心衰)是临床常见、治疗难度较大的一种临床综合征,其治疗主要是以优化药物方案为核心的综合内科治疗,并强调标准化药物治疗及患者的日常生活管理在心衰治疗领域的重要地位。近年来新型药物的研发,为心衰患者的治疗提供了更多选择。本文将总结当前心衰药物治疗及心衰患者管理方面取得的新进展以及存在的不足,旨在更好地提出科学细致的治疗方案和管理模式,以期改善心衰患者预后。Heart failure(HF)is a common clinical syndrome that is difficult to treat in clinical practice.At present,relevant guidelines point out that the treatment of HF is mainly a comprehensive medical treatment with the optimization of drug regimen as the core,and emphasize the important position of standardized drug therapy and daily life management of patients in the field of HF treatment.In recent years,the research and development of new drugs has provided more options for the treatment of patients with heart failure.This article will summarize the new progress and shortcomings made in the current drug treatment of heart failure and the management of patients with heart failure,in order to better propose a scientific and meticulous treatment plan and management model,in order to improve the prognosis of patients with heart failure.

关 键 词：心力衰竭 药物治疗 管理 

分 类 号：R437[医药卫生—临床医学]